STEVANATO GROUP S.P.A. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.65 USD | -1.24% |
|
-5.32% | -24.29% |
Presentation Operator MessageOperator (Operator)Hello, and welcome to today's Stevanato full y...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
Calendar
2024-08-14
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
20.91
USD
Average target price
29.16
USD
Spread / Average Target
+39.45%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -24.29% | 5.72B | |
| -5.35% | 182B | |
| +3.99% | 114B | |
| -3.21% | 68.38B | |
| +6.16% | 52.46B | |
| +8.07% | 44.25B | |
| +7.52% | 43.55B | |
| +25.07% | 32.69B | |
| +17.85% | 26.73B | |
| -0.53% | 25.79B |
- Stock Market
- Equities
- STVN Stock
- News Stevanato Group S.p.A.
- Transcript : Stevanato Group S.p.A., Q4 2021 Earnings Call, Mar 08, 2022
